Promoter to reinvest about Rs 76.18 crore from share sale into medical device expansion

Capex & Operations View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹80.69

prior close

₹78.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-0.3% vs market

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+1.3

15m

+1.1

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-1.6-1.3-0.3

Next day

+0.7-1.3+2.0

+4.4+0.0+4.4

+4.4-0.2+4.6

-0.4-3.0+2.6

-1.5-2.7+1.2

-3.0-1.7-1.2

15d

-13.6-8.9-4.7

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Sachidanand Hariram Upadhyay sold about 90 lakh equity shares (face value Rs 10) on September 29, 2026 through BSE open market for about Rs 76.18 crore in net proceeds. He has proposed reinvesting the majority of these funds into strategic expansion of the company medical device unit through a viable means.

Likely market impact

Promoter reinvesting share sale proceeds into company expansion signals confidence in the medical device business and growth plans.